Self-Identified Medical Cannabis Consumers Report Substituting It for Prescription Drugs
• 22% of respondents reported that medical cannabis has decreased pain (517
• 39% reported that medical cannabis has improved quality of life (900 respondents,
• 61% reported having replaced prescription opioids and benzodiazepines with
medical cannabis (988 respondents, N=1,622).
• 80% of respondents reported using cannabis for chronic pain (2,006 respondents,
• 52% of veteran respondents reported using cannabis for PTSD (299 respondents,
• 18% of respondents said they use illicit cannabis to treat neuropathy, despite this
diagnosis making them eligible for the CUP (468 respondents, N=2,558).
Respondents also reported using cannabis for multiple sclerosis, autism, and
Parkinson’s, all covered by the CUP.
• 64% of respondents who purchase medical cannabis from the illicit market reported
spending between $100 and $500 per month (1,249 respondents, N=1,937).
• 48% of respondents who purchase cannabis through out-of-state medical markets
reported spending between $100 and $500 per month (255 respondents, N=536).
• 84% of respondents have considered leaving Texas for a state with a more inclusive
medical cannabis program (2,033 respondents, N=2,409).